Ameriprise’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Ameriprise’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-372,555	Closed	-$4.29M	–	3829
2018 Q4	$4.29M	Sell	372,555 -55,087	-13%	-$734K	﹤0.01%	2223
2018 Q3	$8.74M	Sell	427,642 -4,226	-1%	-$86.7K	﹤0.01%	1980
2018 Q2	$6.91M	Sell	431,868 -7,910	-2%	-$113K	﹤0.01%	2016
2018 Q1	$6.32M	Buy	439,778 +118,332	+37%	+$1.62M	﹤0.01%	2013
2017 Q4	$4.41M	Buy	321,446 +21,446	+7%	+$385K	﹤0.01%	2227
2017 Q3	$5.76M	Buy	+300,000	New	+$6.48M	﹤0.01%	1994

Other funds holding NITE

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Ameriprise's NITE Position: Q1 2019 in Review

Ameriprise sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q1 2019, closing a stake of 372,555 shares — an estimated $4.29M sold.

Ameriprise first reported a position in NITE in Q3 2017 and held it in 6 quarters. The position peaked at $8.74M in Q3 2018. 53 funds tracked by Wall St. Rank hold NITE as of Q1 2019.

Ameriprise reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
Ameriprise sold 372,555 Nightstar Therapeutics plc American Depositary Shares shares in Q1 2019, an estimated $4.29M.
Ameriprise first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 6 quarters.
Ameriprise's Nightstar Therapeutics plc American Depositary Shares position peaked at $8.74M in Q3 2018.
53 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q1 2019.

Based on Ameriprise's 13F filing for Q1 2019, filed 15 May 2019.